Insider Transactions in Q1 2025 at Neoleukin Therapeutics, Inc. (NLTX)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 26
2025
|
Christine Mikail Cvijic President and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,300
+17.97%
|
-
|
Mar 26
2025
|
Stuart Cobb Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+20.7%
|
-
|
Mar 26
2025
|
Rachel Mc Minn Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,900
+1.84%
|
-
|
Mar 26
2025
|
Julie Jordan Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+50.0%
|
-
|
Mar 13
2025
|
Christine Mikail Cvijic President and CFO |
SELL
Open market or private sale
|
Direct |
4,501
-5.86%
|
$72,016
$16.94 P/Share
|